These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 5755830)

  • 1. [Blood pressure and heart rate of rats after repeated treatment with 2-(2,6-dichlorphenylamino)-2-imidazoline].
    Walland A
    Arzneimittelforschung; 1968 Jul; 18(7):833-6. PubMed ID: 5755830
    [No Abstract]   [Full Text] [Related]  

  • 2. [Central effect of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride].
    Hukuhara T; Otsuka Y; Takeda R; Sukai F
    Arzneimittelforschung; 1968 Sep; 18(9):1147-53. PubMed ID: 5755929
    [No Abstract]   [Full Text] [Related]  

  • 3. [Pharmacological effects of a new antihypertensive agent with imidazoline structure].
    Hoefke W; Kobinger W
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1967; 257(1):28-9. PubMed ID: 4231841
    [No Abstract]   [Full Text] [Related]  

  • 4. Investigations into the mechanism of the hypotensive effect of 2-(2,6-dichlorphenylamino)-2-imidazoline-HCl.
    Kobinger W; Walland A
    Eur J Pharmacol; 1967 Dec; 2(3):155-62. PubMed ID: 5626889
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical and experimental study with the new blood pressure depressant 2-(2,6-dichlorphenylamino)-2-imidazole-hydrochloride].
    Grabner G; Michalek P; Pokorny D; Vormittag E
    Arzneimittelforschung; 1966 Sep; 16(9):1174-9. PubMed ID: 6014738
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of 2-(2,6-dichlorophenylamine)-2-imidazoline HCl on arterial oxygen tension and blood pressure at rest and during exertion].
    Stauch M
    Arzneimittelforschung; 1968 May; 18(5):597-600. PubMed ID: 5755890
    [No Abstract]   [Full Text] [Related]  

  • 7. [Blood circulation studies with 2-(2,6-dichlorphenylamino)-2-imidazoline hydrochloride].
    Kobinger W; Walland A
    Arzneimittelforschung; 1967 Mar; 17(3):292-300. PubMed ID: 5631221
    [No Abstract]   [Full Text] [Related]  

  • 8. [Long-term testing of 2-(2,6-dichlorphenylamino)-2-imidazoline hydrochloride with special reference to the effect on blood pressure and carbohydrate metabolism].
    Krämer D; Krause W; Renner H
    Arzneimittelforschung; 1970 Apr; 20(4):519-21. PubMed ID: 5467817
    [No Abstract]   [Full Text] [Related]  

  • 9. [Single dose studies on the effect of 2-(2,6-dichlorphenylamino)-2-imidazoline-hydrochloride on blood pressure and pulse in hypertonic subjects and on its tolerance].
    Knobloch H; Moor H
    Arzneimittelforschung; 1966 Sep; 16(9):1169-74. PubMed ID: 6014737
    [No Abstract]   [Full Text] [Related]  

  • 10. An investigation into the bradycardic effects of ST 155 [2-(2,6-dichlorophenylamino)-2-imidazoline HCl] in the anesthetized dog.
    Robson RD; Kaplan HR; Laforce S
    J Pharmacol Exp Ther; 1969 Sep; 169(1):120-31. PubMed ID: 4389918
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of 2,6-dichlorphenylamino-imidazoline-HCl on blood pressure and plasma renin activity in rats].
    Rosenthal J; Hoefke W; Wolff HP
    Pflugers Arch; 1969; 312(1):R85-6. PubMed ID: 4311371
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of the hypotensive drug ST 155 (Catapres) on the heart and peripheral circulation.
    Nayler WG; Price JM; Swann JB; McInnes I; Race D; Lowe TE
    J Pharmacol Exp Ther; 1968 Nov; 164(1):45-59. PubMed ID: 5722106
    [No Abstract]   [Full Text] [Related]  

  • 13. [On the hypotensive effect of prednisolone and dexamethasone].
    Podkolzin AA; Tomilets VA
    Farmakol Toksikol; 1969; 32(3):293-6. PubMed ID: 5258233
    [No Abstract]   [Full Text] [Related]  

  • 14. [Mechanism of action of 2-(2,6-dichlorophenylamine)2-imidazoline hydrochloride. Experimental studies in normal animals].
    Brugger A; Oliver R; Salvá JA
    Rev Esp Fisiol; 1970 Mar; 26(1):1-8. PubMed ID: 5431809
    [No Abstract]   [Full Text] [Related]  

  • 15. On the problem of tolerance of 2-(2,6-dichlorophenylamino)-2-imidazoline.
    Walland A; Kobinger W
    Arzneimittelforschung; 1971 Jan; 21(1):61-5. PubMed ID: 5108202
    [No Abstract]   [Full Text] [Related]  

  • 16. Mechanism of action of ST 155 on the blood-pressure in rats.
    Kündig H; Monnier H; Levin NW; Charlton RW
    Arzneimittelforschung; 1967 Nov; 17(11):1440-4. PubMed ID: 5632165
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effects of chronic administration of moxonidine in hypertensive rats SHR-SP].
    Khokhlova ON; Murashev AN; Lavrova LN; Medvedev OS
    Eksp Klin Farmakol; 2000; 63(5):21-3. PubMed ID: 11109519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Behavior of hemodynamic values of patients with hypertension during dichlorphenylamino-imidazoline therapy].
    Pozenel H
    Wien Klin Wochenschr; 1969 Mar; 81(11):187-92. PubMed ID: 4935483
    [No Abstract]   [Full Text] [Related]  

  • 19. Evidence that some imidazoline derivatives inhibit peripherally the vasopressor sympathetic outflow in pithed rats.
    Monroy-Ordoñez EB; Villalón CM; Cobos-Puc LE; Márquez-Conde JA; Sánchez-López A; Centurión D
    Auton Neurosci; 2008 Dec; 143(1-2):40-5. PubMed ID: 18774761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of moxonidine on the cardiac chronotropic regulation in hypertensive rats SHR-SP].
    Khokhlova ON; Murashov AN; Lavrova LN; Medvedev OS
    Eksp Klin Farmakol; 2001; 64(1):42-5. PubMed ID: 11544803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.